Knowledge of pharmacovigilance among healthcare professionals and the impact of an educational intervention.
adverse drug reaction
doctors
knowledge
nurses
pharmacovigilance
Journal
Medicine and pharmacy reports
ISSN: 2668-0572
Titre abrégé: Med Pharm Rep
Pays: Romania
ID NLM: 101742144
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
14
02
2021
revised:
15
03
2022
accepted:
31
01
2023
medline:
16
11
2023
pubmed:
16
11
2023
entrez:
16
11
2023
Statut:
ppublish
Résumé
To determine the knowledge regarding various aspects of pharmacovigilance among doctors and nurses of a tertiary care teaching hospital and to evaluate the effect of an educational intervention. A cross-sectional study was conducted among doctors and nurses of a tertiary care teaching hospital. The participants attended a one-hour educational session during which the concept of pharmacovigilance, the Pharmacovigilance Program of India, the need for reporting ADRs, and the method of reporting were explained by a subject expert. A 20-item questionnaire was used to assess their knowledge regarding pharmacovigilance before and after an educational session. The pre-post comparisons were done using Wilcoxon's signed-rank test. A p-value less than 0.05 was considered statistically significant. Forty-two doctors and 115 nurses participated in the study. A significant improvement in the participant scores was seen following the educational intervention in both doctors (Z = -5.344, p < 0.001) and nurses (Z = -8.808, p < 0.001). Lack of knowledge/awareness was perceived as the major barrier for ADR reporting among nurses as well as doctors. There is need for education and training among doctors and nurses to enhance their knowledge about drug safety and reporting practices. Educational intervention is likely to improve the knowledge regarding pharmacovigilance, and thereby enhance reporting by healthcare professionals.
Identifiants
pubmed: 37970197
doi: 10.15386/mpr-2076
pii: cm-96-406
pmc: PMC10642735
doi:
Types de publication
Journal Article
Langues
eng
Pagination
406-412Références
Perspect Clin Res. 2015 Jan-Mar;6(1):45-52
pubmed: 25657902
PLoS One. 2016 Mar 24;11(3):e0152221
pubmed: 27010447
BMC Med Educ. 2020 Jun 3;20(1):179
pubmed: 32493307
BMC Res Notes. 2017 Jan 3;10(1):4
pubmed: 28057047
Drug Saf. 2012 Dec 1;35(12):1171-82
pubmed: 23072620
PLoS One. 2020 Oct 27;15(10):e0241377
pubmed: 33108377
PLoS One. 2020 Aug 13;15(8):e0235591
pubmed: 32790671
Eur J Clin Pharmacol. 2018 Oct;74(10):1235-1248
pubmed: 29926135
Drug Saf. 2018 Nov;41(11):1003-1011
pubmed: 29949100
J Nat Sci Biol Med. 2017 Jul-Dec;8(2):203-209
pubmed: 28781488
Rev Saude Publica. 2016;50:14
pubmed: 27143614
BMJ Open. 2012 Jan 13;2:e000367
pubmed: 22246555
Int J Risk Saf Med. 2013;25(4):197-204
pubmed: 24305558
Clinics (Sao Paulo). 2017 Jan 01;72(1):51-57
pubmed: 28226033
Eur J Clin Pharmacol. 2020 Jul;76(7):991-1001
pubmed: 32296857
Int J Clin Pract. 2021 Nov;75(11):e14731
pubmed: 34387008
Ther Adv Drug Saf. 2019 Jan 25;10:2042098618816279
pubmed: 30719280